Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Potential Biologic Warfare Agent Disables Neutrophil Response

By Biotechdaily staff writers
Posted on 28 Dec 2006
Researchers have learned how the causative agent of tularemia, Francisella tularensis, infects and survives in blood cells that normally destroy invading bacteria. More...
While F tularensis rarely infects people, its potential to be used as a bio-terrorist tool has generated increased interest in understanding its life cycle.

Investigators at the University of Iowa (Iowa City, USA) were primarily interested in finding out why despite being able to ingest F tularensis, human blood neutrophils were unable to kill them.

Results published in the December 2006 issue of the Journal of Leukocyte Biology demonstrated that the bacteria's ability to disrupt the neutrophils' "respiratory burst” was largely responsible for their ability to survive. This evidence was provided by luminol-enhanced chemiluminescence and nitroblue tetrazolium staining, which showed that neutrophils infected with live F tularensis did not generate reactive oxygen species.

"We wanted to better understand how Francisella tularensis could overcome the body's innate immune response and cause disease. In addition, learning more about this bacterium can help us learn more about the overall human immune response to bacteria,” explained senior author Dr. Lee-Ann Allen, associate professor of internal medicine and microbiology at the University of Iowa. "The rate of tularemia infection has significantly declined since the 1940s. However, the bacteria would be very deadly as an aerosolized terrorist weapon--inhaling as few as 10 bacteria could be potentially deadly.”



Related Links:
University of Iowa

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.